Exelixis Inc Shares Outstanding (Cover Page)
Exelixis Inc (EXEL) had Shares Outstanding (Cover Page) of 247.78 million shares as of 2026-07-27, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-27: Entity Common Stock, Shares Outstanding 247.78M shares.
- 2026-04-27: Entity Common Stock, Shares Outstanding 251.36M shares.
- 2026-02-02: Entity Common Stock, Shares Outstanding 259.71M shares.
- 2025-10-27: Entity Common Stock, Shares Outstanding 268.11M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-27 | 247.78M shares 10-Q · filed 2026-08-05 |
| 2026-04-27 | 251.36M shares 10-Q · filed 2026-05-05 |
| 2026-02-02 | 259.71M shares 10-K · filed 2026-02-10 |
| 2025-10-27 | 268.11M shares 10-Q · filed 2025-11-04 |
| 2025-07-21 | 269.20M shares 10-Q · filed 2025-07-28 |
| 2025-05-05 | 272.71M shares 10-Q · filed 2025-05-13 |
| 2025-02-03 | 279.88M shares 10-K · filed 2025-02-11 |
| 2024-10-21 | 285.58M shares 10-Q · filed 2024-10-29 |
| 2024-07-29 | 285.25M shares 10-Q · filed 2024-08-06 |
| 2024-04-22 | 291.29M shares 10-Q · filed 2024-04-30 |
| 2024-01-29 | 303.19M shares 10-K · filed 2024-02-06 |
| 2023-10-23 | 310.97M shares 10-Q · filed 2023-11-01 |
| 2023-07-24 | 318.38M shares 10-Q · filed 2023-08-01 |
| 2023-05-01 | 325.64M shares 10-Q · filed 2023-05-09 |
| 2023-01-30 | 324.09M shares 10-K · filed 2023-02-07 |
| 2022-10-24 | 322.56M shares 10-Q · filed 2022-11-01 |
| 2022-08-01 | 321.83M shares 10-Q · filed 2022-08-09 |
| 2022-05-02 | 320.74M shares 10-Q · filed 2022-05-10 |
| 2022-02-07 | 319.45M shares 10-K · filed 2022-02-18 |
| 2021-10-25 | 316.40M shares 10-Q · filed 2021-11-02 |
| 2021-07-26 | 315.05M shares 10-Q · filed 2021-08-05 |
| 2021-04-26 | 313.39M shares 10-Q · filed 2021-05-06 |
| 2021-02-01 | 311.99M shares 10-K · filed 2021-02-11 |
| 2020-10-26 | 310.24M shares 10-Q · filed 2020-11-05 |
| 2020-07-27 | 309.00M shares 10-Q · filed 2020-08-06 |
| 2020-04-27 | 306.66M shares 10-Q · filed 2020-05-05 |
| 2020-02-18 | 305.39M shares 10-K · filed 2020-02-25 |
| 2019-10-21 | 303.85M shares 10-Q · filed 2019-10-30 |
| 2019-07-22 | 302.91M shares 10-Q · filed 2019-07-31 |
| 2019-04-22 | 301.77M shares 10-Q · filed 2019-05-01 |
| 2019-02-12 | 300.13M shares 10-K · filed 2019-02-22 |
| 2018-10-22 | 298.98M shares 10-Q · filed 2018-11-01 |
| 2018-07-24 | 298.04M shares 10-Q · filed 2018-08-01 |
| 2018-04-23 | 296.87M shares 10-Q · filed 2018-05-02 |
| 2018-02-12 | 296.31M shares 10-K · filed 2018-02-26 |
| 2017-10-24 | 295.85M shares 10-Q · filed 2017-11-01 |
| 2017-07-26 | 293.90M shares 10-Q · filed 2017-08-02 |
| 2017-04-24 | 292.51M shares 10-Q · filed 2017-05-01 |
| 2017-02-16 | 290.87M shares 10-K · filed 2017-02-27 |
| 2016-10-26 | 286.46M shares 10-Q · filed 2016-11-03 |
| 2016-07-28 | 230.33M shares 10-Q · filed 2016-08-03 |
| 2016-04-28 | 228.74M shares 10-Q · filed 2016-05-04 |
| 2016-02-19 | 228.19M shares 10-K · filed 2016-02-29 |
| 2015-10-29 | 227.22M shares 10-Q · filed 2015-11-10 |
| 2015-08-03 | 225.43M shares 10-Q · filed 2015-08-11 |
| 2015-04-23 | 196.03M shares 10-Q · filed 2015-04-30 |
| 2015-02-26 | 195.90M shares 10-K · filed 2015-03-02 |
| 2014-10-29 | 195.22M shares 10-Q · filed 2014-11-04 |
| 2014-07-24 | 195.11M shares 10-Q · filed 2014-07-31 |
| 2014-04-24 | 194.69M shares 10-Q · filed 2014-05-01 |
| 2014-02-18 | 194.61M shares 10-K · filed 2014-02-20 |
| 2013-10-25 | 184.20M shares 10-Q · filed 2013-10-30 |
| 2013-07-29 | 184.12M shares 10-Q · filed 2013-08-06 |
| 2013-04-30 | 183.80M shares 10-Q · filed 2013-05-07 |
| 2013-02-14 | 183.72M shares 10-K · filed 2013-02-21 |
| 2012-11-02 | 183.60M shares 10-Q · filed 2012-11-07 |
| 2012-07-27 | 148.88M shares 10-Q · filed 2012-08-02 |
| 2012-04-27 | 148.48M shares 10-Q · filed 2012-05-03 |
| 2012-02-15 | 148.42M shares 10-K · filed 2012-02-22 |
| 2011-10-21 | 129.69M shares 10-Q · filed 2011-10-27 |
| 2011-07-29 | 128.97M shares 10-Q · filed 2011-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |